1.22
price up icon4.27%   0.05
after-market Handel nachbörslich: 1.29 0.07 +5.74%
loading

Finanzdaten der Iterum Therapeutics Plc-Aktie (ITRM)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
46.09%
6.163
11.43 16.68 10.82 8.53
Operating Income/Loss
46.09%
-6.163
-11.43 -16.68 -10.82 -8.53
Nonoperating Income/Loss
12.80%
-0.89
-0.789 12.97 -1.234 -1.236
Income/Loss From Continuing Operations Before Tax
42.28%
-7.053
-12.22 -3.716 -12.06 -9.766
Income Tax Expense/Benefit
66.20%
0.048
0.142 0.161 0.187 0.123
Income/Loss From Continuing Operations After Tax
42.56%
-7.101
-12.36 -3.877 -12.24 -9.889
Net Income/Loss
42.56%
-7.101
-12.36 -3.877 -12.24 -9.889
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
20,899%
15.43
0.0735 13.04 12.94 12.68
Diluted Average Shares
20,899%
15.43
0.0735 13.04 12.94 12.68
Basic Earnings Per Share
51.06%
-0.46
-0.94 -0.30 -0.95 -0.78
Diluted Earnings Per Share
51.06%
-0.46
-0.94 -0.30 -0.95 -0.78
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$73.44
price up icon 2.00%
$68.32
price up icon 0.56%
$31.28
price up icon 0.35%
$20.46
price up icon 8.83%
$93.32
price up icon 3.36%
biotechnology ONC
$274.78
price up icon 1.38%
Kapitalisierung:     |  Volumen (24h):